Download PDF
Semin Speech Lang 2004; 25(2): 169-180
DOI: 10.1055/s-2004-825653
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Parkinson's Disease: Speech and Voice Disorders and Their Treatment with the Lee Silverman Voice Treatment

Lorraine Olson Ramig1 , 2 , 3 , Cynthia Fox2 , Shimon Sapir2 , 4
  • 1Professor, Department of Speech, Language, Hearing Sciences, University of Colorado-Boulder, Boulder, Colorado
  • 2National Center for Voice and Speech, Denver, Colorado
  • 3Department of Biobehavior, Columbia University, Teacher's College, New York, New York
  • 4Department of Communication Sciences and Disorders, Faculty of Social Welfare and Health Studies, University of Haifa, Haifa, Israel
Further Information

Publication History

Publication Date:
07 May 2004 (online)

    Permissions and Reprints

Speech and voice disorders are very common among individuals suffering from idiopathic Parkinson's disease. In this article we review evidence for laryngeal, respiratory, articulatory, and velopharyngeal disorders in this population. We present the essential concepts and outcome data for the Lee Silverman Voice Treatment®, a behavioral treatment program that has yielded significant long-term improvement in speech and voice functions in individuals with idiopathic Parkinson's disease.

KEYWORDS

Parkinson's disease - voice - speech - LSVT® - Lee Silverman Voice Treatment®

REFERENCES

  • 1 Scott S, Caird F I, Williams B O. Communication in Parkinson's Disease. Rockville, MD; Aspen 1985
    Google Scholar
  • 2 Canter G J. Speech characteristics of patients with Parkinson's disease: III. Articulation, diadochokinesis and overall speech adequacy.  J Speech Hear Disord. 1965;  30 217-224
    CrossrefPubMedGoogle Scholar
  • 3 Canter G J. Speech characteristics of patients with Parkinson's disease: II. Physiological support for speech.  J Speech Hear Disord. 1965;  30 44-49
    CrossrefPubMedGoogle Scholar
  • 4 Logemann J, Fisher H, Boshes B, Blonsky E. Frequency and concurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients.  J Speech Hear Disord. 1978;  43 47-57
    PubMedGoogle Scholar
  • 5 Oxtoby M. Parkinson's Disease Patients and Their Social Needs. London; Parkinson's Disease Society 1982
    Google Scholar
  • 6 Streifler M, Hofman S. Disorders of verbal expression in Parkinsonism. In: Hassler RG, Christ JF Advances in Neurology. New York; Raven Press 1984: 385-393
    Google Scholar
  • 7 Hartelius L, Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey.  Folia Phoniatr Logop. 1994;  46 9-17
    CrossrefPubMedGoogle Scholar
  • 8 Aronson A E. Clinical Voice Disorders. New York; Thieme-Stratton 1990
    Google Scholar
  • 9 Ho A K, Iansek R, Marigliani C, Bradshaw J L, Gates S. Speech impairment in a large sample of patients with Parkinson's disease.  Behav Neurol. 1998;  11 131-137
    PubMedGoogle Scholar
  • 10 Sapir S, Ramig L, Hoyt P, O'Brien C, Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment.  Folia Phoniatr. 2002;  54 296-303
    CrossrefPubMedGoogle Scholar
  • 11 Darley F L, Aronson A E, Brown J R. Motor Speech Disorders. Philadelphia; WB Saunders 1975
    Google Scholar
  • 12 Barbeau A, Sourkes T L, Murphy C F. Les Catecholamines de la Maladie de Parkinson's. In: Ajuriaguerra J Monoamines et Système Nerveux Central. Genève; George 1962
    Google Scholar
  • 13 Svennilson E, Torvik A, Lowe R, Leksall L. Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical evaluation of 81 cases.  Acta Psychiatr Scand. 1960;  35 358-377
    PubMedGoogle Scholar
  • 14 Freed C R, Breeze R E, Rosenberg N L et al.. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.  N Engl J Med. 1992;  327 1549-1555
    PubMedGoogle Scholar
  • 15 Larson K, Ramig L O, Scherer R C. Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson's disease.  J Med Speech Lang Pathol. 1994;  2 211-226
    PubMedGoogle Scholar
  • 16 Baker K K, Ramig L O, Johnson A B, Freed C R. Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease.  J Speech Lang Hear Res. 1997;  40 615-626
    PubMedGoogle Scholar
  • 17 Yorkston K M. Treatment efficacy: dysarthria.  J Speech Hear Res. 1996;  39 S46-S57
    PubMedGoogle Scholar
  • 18 Helm N. Management of palilalia with a pacing board.  J Speech Hear Disord. 1979;  44 350-353
    CrossrefPubMedGoogle Scholar
  • 19 Yorkston K M, Spencer K A, Duffy J R. Behavioral management of respiratory/phonatory dysfunction from dysarthria: a systematic review of the evidence.  J Med Speech Lang Pathol. 2003;  11 xiii-xxxviii
    PubMedGoogle Scholar
  • 20 Ramig L, Countryman S, Thompson L, Horii Y. Comparison of two forms of intensive speech treatment for Parkinson disease.  J Speech Hear Res. 1995;  38 1232-1251
    CrossrefPubMedGoogle Scholar
  • 21 Ramig L O, Countryman S, O'Brien C, Hoehn M, Thompson L. Intensive speech treatment for patients with Parkinson's disease: short and long term comparison of two techniques.  Neurology. 1996;  47 1496-1504
    CrossrefPubMedGoogle Scholar
  • 22 Halpern A, Midos C, Ramig L, Spielman J, Bennett I. A PDA-enhanced speech treatment for Parkinson's disease. Presented at: Twealth Biannual Conference Albuquerque, NM; March 2004
    Google Scholar
  • 23 Leanderson R, Meyerson B A, Persson A. Effect of L-dopa on speech in Parkinsonism an EMG study of labial articulatory function.  J Neurol Neurosurg Psychiatry. 1971;  34 679-681
    PubMedGoogle Scholar
  • 24 Moore C A, Scudder R R. Coordination of jaw muscle activity in Parkinsonian movement: description and response to traditional treatment. In: Yorkston KM, Beukelman DR Recent Advances in Clinical Dysarthria. Boston, MA; College-Hill Press 1989
    Google Scholar
  • 25 Baker K, Ramig L O, Luschei E, Smith M. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging.  Neurology. 1998;  51 1592-1598
    CrossrefPubMedGoogle Scholar
  • 26 Hansen D G, Gerratt B R, Ward P H. Cinegraphic observations of laryngeal function in Parkinson's disease.  Laryngoscope. 1984;  94 348-353
    PubMedGoogle Scholar
  • 27 Ackermann H, Ziegler W. Articulatory deficits in Parkinsonian dysarthria.  J Neurol Neurosurg Psychiatry. 1991;  54 1093-1098
    CrossrefPubMedGoogle Scholar
  • 28 Hoodin R B, Gilbert H R. Nasal airflows in Parkinsonian speakers.  J Commun Disord. 1989a;  22 169-180
    CrossrefPubMedGoogle Scholar
  • 29 Ho A K, Bradshaw J L, Iansek R, Alfredson R. Speech volume regulation in Parkinson's disease: effects of implicit cues and explicit instructions.  Neuropsychologia. 1999;  37 1453-1460
    CrossrefPubMedGoogle Scholar
  • 30 Ho A K, Bradshaw J L, Iansek T. Volume perception in Parkinsonian speech.  Move Disord. 2000;  15 1125-1131
    PubMedGoogle Scholar
  • 31 Darley F L, Aronson A E, Brown J R. Clusters of deviant speech dimensions in the dysarthrias.  J Speech Hear Res. 1969;  12 462-469
    CrossrefPubMedGoogle Scholar
  • 32 Darley F L, Aronson A, Brown J. Differential diagnostic patterns of dysarthria.  J Speech Hear Res. 1969;  12 246-269
    CrossrefPubMedGoogle Scholar
  • 33 Logemann J, Boshes B, Fisher H. The steps in the degeneration of speech and voice control in Parkinson's disease. In: Siegfried J Parkinson's Diseases: Rigidity, Akinesia, Behavior. Vienna; Hans Huber 1973: 101-112
    Google Scholar
  • 34 Stewart C, Winfield L, Hunt A et al.. Speech dysfunction in early Parkinson's disease.  Move Disord. 1995;  10 562-565
    PubMedGoogle Scholar
  • 35 Ludlow C L, Bassich C J. Relationships between perceptual ratings and acoustic measures of hypokinetic speech. In: McNeil MR, Rosenbek JC, Aronson AE The Dysarthrias: Physiology, Acoustics, Perception, Management. San Diego, CA; College-Hill 1984: 103-196
    Google Scholar
  • 36 Canter G J. Speech characteristics of patients with Parkinson's disease: I. Intensity, pitch and duration.  J Speech Hear Disord. 1963;  28 221-229
    CrossrefPubMedGoogle Scholar
  • 37 Metter E J, Hanson W R. Clinical and acoustical variability in hypokinetic dysarthria.  J Commun Disord. 1986;  19 347-366
    CrossrefPubMedGoogle Scholar
  • 38 Fox C, Ramig L. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease.  Am J Speech Lang Pathol. 1997;  2 29-42
    PubMedGoogle Scholar
  • 39 Ho A K, Iansek R, Bradshaw J L. Motor instability in Parkinsonian speech intensity.  Neuropsychiatry Neuropsychol Behav Neurol. 2001;  14 109-116
    PubMedGoogle Scholar
  • 40 King J, Ramig L, Lemke J H, Horii Y. Parkinson's disease: longitudinal changes in acoustic parameters of phonation.  J Med Speech Lang Pathol. 1994;  2 29-42
    PubMedGoogle Scholar
  • 41 Ramig L, Scherer R C, Titze I R, Ringel S P. Acoustic analysis of voices of patients with neurologic disease: rationale and preliminary data.  Ann Otolaryngol Rhinol Laryngol. 1988;  97 164-172
    PubMedGoogle Scholar
  • 42 Ramig L O, Shipp T. Comparative measures of vocal tremor and vocal vibrato.  J Voice. 1987;  1 162-167
    CrossrefPubMedGoogle Scholar
  • 43 Ludlow C L, Bassich C J, Connor N P, Coulter D C. Phonatory characteristics of vocal fold tremor.  J Phonetics. 1986;  14 509-515
    PubMedGoogle Scholar
  • 44 Winholtz W S, Ramig L O. Vocal tremor analysis with the vocal demodulator.  NCVS Status Prog Rep. 1992;  2 119-137
    PubMedGoogle Scholar
  • 45 Smith M, Ramig L O, Dromey C, Perez K, Samandari R. Intensive voice treatment in Parkinson's disease: laryngostroboscopic findings.  J Voice. 1995;  9 453-459
    CrossrefPubMedGoogle Scholar
  • 46 Perez K, Ramig L O, Smith M, Dromey C. The Parkinson larynx: tremor and videostroboscopic findings.  J Voice. 1996;  10 354-361
    CrossrefPubMedGoogle Scholar
  • 47 Luschei E S, Ramig L O, Baker K L, Smith M. Discharge characteristics of laryngeal single motor units during phonation in young and older adults and in persons with Parkinson disease.  J Neurophysiol. 1999;  81 2131-2139
    PubMedGoogle Scholar
  • 48 De la Torre R, Mier M, Boshes B. Evaluation of respiratory function: preliminary observations.  Q Bull Northwestern University Med Sch. 1960;  34 332-336
    PubMedGoogle Scholar
  • 49 Mueller P B. Parkinson's disease: motor-speech behavior in a selected group of patients.  Folia Phoniatr (Basel). 1971;  23 333-346
    CrossrefPubMedGoogle Scholar
  • 50 Solomon N P, Hixon T J. Speech breathing in Parkinson's disease.  J Speech Hear Res. 1993;  36 294-310
    PubMedGoogle Scholar
  • 51 Schiffman P L. A “saw-tooth” pattern in Parkinson's disease.  Chest. 1985;  87 124-126
    PubMedGoogle Scholar
  • 52 Vincken W G, Gauthier S G, Dollfuss R E, Hanson R E, Parauay C M, Cosio M G. Involvement of upper-airway muscles in extrapyramidal disorders, a cause of airflow limitation.  N Engl J Med. 1984;  311 438-442
    CrossrefPubMedGoogle Scholar
  • 53 Murdoch B E, Chenery H J, Bowler S, Ingram J CL. Respiratory function in Parkinson's subjects exhibiting a perceptible speech deficit: a kinematic and spirometric analysis.  J Speech Hear Disord. 1989;  54 610-626
    PubMedGoogle Scholar
  • 54 Adams S G. Hypokinetic dysarthria in Parkinson's Disease. In: McNeil MR Clinical Management of Sensorimotor Speech Disorders. New York; Thieme 1997
    Google Scholar
  • 55 Sapir S, Pawlas A A, Ramig L O et al.. Voice and speech abnormalities in Parkinson disease: relation to severity of motor impairment, duration of disease, medication, depression, gender, and age.  J Med Speech Lang Pathol. 2001;  9 213-226
    PubMedGoogle Scholar
  • 56 Weismer G. Articulatory characteristics of Parkinsonian dysarthria: segmental and phrase-level timing, spirantization and glottal-supraglottal coordination. In: McNeil MR, Rosenbek J, Aronson AE The Dysarthrias: Physiology, Acoustics, Perception and Management. San Diego, CA; College Hill Press 1984: 101-129
    Google Scholar
  • 57 Forrest K, Weismer G, Turner G. Kinematic, acoustic and perceptual analysis of connected speech produced by Parkinsonian and normal geriatric adults.  J Acoust Soc Am. 1989;  85 2608-2622
    CrossrefPubMedGoogle Scholar
  • 58 Ackermann H, Konczak J, Hertrich I. The temporal control of repetitive articulatory movements in Parkinson's disease.  Brain Lang. 1997;  56 312-319
    CrossrefPubMedGoogle Scholar
  • 59 Caligiuiri M P. Labial kinematics during speech in patients with Parkinsonian rigidity.  Brain. 1987;  110 1033-1044
    PubMedGoogle Scholar
  • 60 Conner N P, Abbs J H, Cole K J, Gracco V L. Parkinsonian deficits in serial mulitarticulate movements for speech.  Brain. 1989;  112(pt. 4) 997-1009
    PubMedGoogle Scholar
  • 61 Hirose H. Pathophysiology of motor speech disorders (dysarthria).  Folia Phoniatr (Basel). 1986;  38 61-88
    PubMedGoogle Scholar
  • 62 Gath I, Yair E. Analysis of vocal tract parameters in Parkinsonian speech.  J Acoust Soc Am. 1988;  84 1628-1634
    PubMedGoogle Scholar
  • 63 Hunker C J, Abbs J H. Physiological analyses of Parkinsonian tremors in the orofacial system. In: McNeil MR, Rosenbek JC, Aronson AE The Dysarthrias: Physiology, Acoustics, Perception, Management. San Diego, CA; College-Hill Press 1984
    Google Scholar
  • 64 Netsell R, Daniel B, Celesia G G. Acceleration and weakness in Parkinsonian dysarthria.  J Speech Hear Disord. 1975;  40 170-178
    CrossrefPubMedGoogle Scholar
  • 65 Schneider J S, Diamond S G, Markham C H. Deficits in orofacial sensorimotor function in Parkinson's's disease.  Ann Neurol. 1986;  19 275-282
    CrossrefPubMedGoogle Scholar
  • 66 Schneider J S, Lidsky T I. Basal Ganglia and Behavior: Sensory Aspects of Motor Functioning. Toronto; Hans Huber 1987
    Google Scholar
  • 67 Caligiuri M P. Labial kinematics during speech in patients with parkinsonian rigidity.  Brain. 1987;  110 1033-1044
    PubMedGoogle Scholar
  • 68 Connor N P, Abbs J H, Cole K J, Gracco V L. Parkinsonian deficits in serial multiarticulate movements for speech.  Brain. 1989;  112 997-1009
    PubMedGoogle Scholar
  • 69 Hoodin R B, Gilbert H R. Parkinsonian dysarthria: an aerodynamic and perceptual description of velopharyngeal closure for speech.  Folia Phoniatr (Basel). 1989;  41 249-258
    PubMedGoogle Scholar
  • 70 Koller W C. Sensory symptoms in PD.  Neurology. 1984;  34 957-959
    CrossrefPubMedGoogle Scholar
  • 71 Tatton W G, Eastman M J, Bedingham W, Verrier M C, Bruce I C. Defective utilization of sensory input as the basis for bradykinesia, rigidity and decreased movement repertoire in Parkinson's disease: a hypothesis.  Can J Neurol Sci. 1984;  11 136-143
    PubMedGoogle Scholar
  • 72 Diamond S G, Schneider J S, Markham C H. Oral sensorimotor defects in patients with Parkinson's disease.  Adv Neurol. 1987;  45 335-338
    PubMedGoogle Scholar
  • 73 Solomon N P, Robin D A, Lorell D M, Rodnitzky R L, Luschei E S. Tongue function testing in Parkinson's disease: indicators of fatigue. In: Till JA, Yorkston KM, Beukelman DR Motor Speech Disorders: Advances in Assessment and Treatment. Baltimore, MD; Paul H Brooks 1994: 147-160
    Google Scholar
  • 74 Fox C M, Morrison C E, Ramig L O, Sapir S. Current perspectives on the Lee Silverman Voice Treatment (LSVT®) for individuals with idiopathic Parkinson's disease.  Am J Speech Lang Pathol. 2002;  11 111-123
    PubMedGoogle Scholar
  • 75 Ramig L O, Pawlas A, Countryman S. The Lee Silverman Voice Treatment (LSVT®): A Practical Guide to Treating the Voice and Speech Disorders in Parkinson Disease. Iowa City, IA; National Center for Voice and Speech 1995
    Google Scholar
  • 76 Ho A K, Iansek R, Bradshaw J L. Regulations of parkinsonian speech volume: the effect of interlocuter distance.  J Neurol Neurosurg Psychiatry. 1999;  67 199-202
    CrossrefPubMedGoogle Scholar
  • 77 Curio G, Neuloh G, Numminen J, Jousmaki V, Hari R. Speaking modifies voice-evoked activity in the human auditory cortex.  Hum Brain Mapp. 2000;  9 183-191
    CrossrefPubMedGoogle Scholar
  • 78 Albin R L, Young A B, Penny J B. The functional anatomy of basal ganglia disorders.  Trends Neurosci. 1989;  12 366-375
    CrossrefPubMedGoogle Scholar
  • 79 Penny J B, Young A B. Speculations on the functional anatomy of basal ganglia disorders.  Annu Rev Neurosci. 1983;  6 73-94
    CrossrefPubMedGoogle Scholar
  • 80 Berardelli A, Dick J P, Rothwell J C, Day B L, Marsden C D. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease.  J Neurol Neurosurg Psychiatry. 1986;  49 1273-1279
    PubMedGoogle Scholar
  • 81 Demirci M, Grill, McShane, Hallet M. A mismatch between kinesthesia and visual perception in Parkinson's disease.  Ann Neurol. 1997;  41 781-788
    CrossrefPubMedGoogle Scholar
  • 82 Critchley E MR. Speech disorders of Parkinsonism: a review.  J Neurol Neurosurg Psychiatry. 1981;  44 751-758
    PubMedGoogle Scholar
  • 83 Rigrodsky S, Morrison E B. Speech changes in Parkinsonism during L-dopa therapy: preliminary findings.  J Am Geriatr Soc. 1970;  18 142-151
    PubMedGoogle Scholar
  • 84 Wolfe V I, Garvin J S, Bacon M, Waldrop W. Speech changes in Parkinson's disease during treatment with L-dopa.  J Commun Disord. 1975;  8 271-279
    CrossrefPubMedGoogle Scholar
  • 85 Countryman S, Ramig L O. Effects of intensive voice therapy on speech deficits associated with bilateral thalamotomy in Parkinson's disease: a case study.  J Med Speech Lang Pathol. 1993;  1 233-249
    PubMedGoogle Scholar
  • 86 Ghika J, Ghika-Schmid F, Fankhauser H et al.. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature.  J Neurosurg. 1999;  91 313-321
    PubMedGoogle Scholar
  • 87 Schulz G M, Peterson T, Sapienza C M, Greer M, Friedman W. Voice and speech characteristics of persons with Parkinson's disease pre- and post-pallidotomy surgery: preliminary findings.  J Speech Lang Hear Res. 1999;  42 1176-1194
    PubMedGoogle Scholar
  • 88 Sarno M T. Speech impairment in Parkinson's disease.  Arch Phys Med Rehabil. 1968;  269-275
    PubMedGoogle Scholar
  • 89 Allan C M. Treatment of non fluent speech resulting from neurological disease-treatment of dysarthria.  Br J Disord Commun. 1970;  5 3-5
    PubMedGoogle Scholar
  • 90 Scott S, Caird F L. Speech therapy for Parkinson's disease.  J Neurol Neurosurg Psychiatry. 1983;  46 140-144
    PubMedGoogle Scholar
  • 91 McNamara P, Obler L K, Au R, Durso R, Albert M L. Speech monitoring skills in Alzheimer's disease, Parkinson's disease and normal aging.  Brain Lang. 1992;  42 38-51
    CrossrefPubMedGoogle Scholar
  • 92 Schmidt R A. Motor Control and Learning. Champaign, IL; Human Kinetic Publishers 1988
    Google Scholar
  • 93 Astrand P O, Rodahl K. Textbook of Work Physiology. New York; McGraw-Hill 1970
    Google Scholar
  • 94 Ramig L O, Bonitati C, Lemke J, Horii Y. Voice treatment for patients with Parkinson disease: development of an approach and preliminary efficacy data.  J Med Speech Lang Pathol. 1994;  2 191-209
    PubMedGoogle Scholar
  • 95 Ramig L O. The role of phonation in speech intelligibility: a review and preliminary data from patients with Parkinson's disease. In: Kent RD Intelligibility in Speech Disorders: Theory, Measurement and Management. Amsterdam; John Benjamin 1992: 119-155
    Google Scholar
  • 96 Dromey C, Ramig L O, Johnson A. Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study.  J Speech Hear Res. 1995;  38 751-763
    PubMedGoogle Scholar
  • 97 Ramig L O, Sapir S, Countryman S et al.. Intensive voice treatment (LSVT®) for individuals with Parkinson's disease: a 2-year follow-up.  J Neurol Neurosurg Psychiatry. 2001;  71 493-498
    CrossrefPubMedGoogle Scholar
  • 98 Baumgartner C, Sapir S, Ramig L O. Voice quality changes following phonatory-respiratory effort treatment (LSVT®) versus respiratory effort treatment for individuals with Parkinson disease.  J Voice. 2001;  15 105-114
    CrossrefPubMedGoogle Scholar
  • 99 Sapir S, Ramig L O, Hoyt P, Countryman S, O'Brien C, Hoehn M. Phonatory-respiratory effort (LSVT®) vs. respiratory effort treatment for hypokinetic dysarthria: comparing speech loudness and quality before and 12 months after treatment. Poster presented at: Academy of Neurology Vancouver, Canada; October 1999
    Google Scholar
  • 100 Ramig L, Sapir S, Fox C, Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and with normal age-matched controls.  Mov Disord. 2001;  16 79-83
    CrossrefPubMedGoogle Scholar
  • 101 Ramig L O, Dromey C. Aerodynamic mechanisms underlying treatment-related changes in SPL in patients with Parkinson disease.  J Speech Hear Res. 1996;  39 798-807
    PubMedGoogle Scholar
  • 102 Countryman S, Ramig L O, Pawlas A A. Speech and voice deficits in Parkinsonian Plus syndromes: can they be treated?.  J Med Speech Lang Pathol. 1994;  2 211-225
    PubMedGoogle Scholar
  • 103 Schulman R. Articulatory dynamics of loud and normal speech.  J Acoust Soc Am. 1989;  85 295-312
    PubMedGoogle Scholar
  • 104 Ramig L O, Dromey C, Johnson A, Scherer R. The effects of phonatory, respiratory and articulatory effect treatment on speech and voice in Parkinson's disease. Paper presented at: Motor Speech Conference April 1994 Sedona, AZ;
    Google Scholar
  • 105 Liotti M, Ramig L O, Vogel D et al.. Hypophonia in Parkinson's disease neural correlates of voice treatment revealed by PET.  Neurology. 2003;  60 432-440
    PubMedGoogle Scholar

Lorraine Olson RamigPh.D. CCC-SLP 

Department of Speech, Language, Hearing Science

Campus Box 409, University of Colorado-Boulder

Boulder, CO 80309

Email: ramig@spot.colorado.edu

      >